Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan.

Salvatore Annunziata*, Maria Lucia Calcagni, Luca Indovina, Vittoria Rufini

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

4 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan.'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science